I think continue doing what we are doing. Share with physicians, representatives and so forth.

The difficult truth, IMO, is that is difficult to get attention with big players also advancing new therapies and running multiple trials.

We have beaten the dead horse, but it is inescapable that there will not be further regulatory progress until we have clinical evidence of efficacy. The safety data drove me to invest more, but alone will not get an EAU.

If Cytodyn presents strong data and no EUA, then it is time to really go a bit nuts and leverage any contacts we have. Until then, I feel it is time to invest and plan.

I just don't buy all the claims of deep conspiracies. The processes are in place because they generally work.